Background: Recommendations for treatment of ventilator-associated pneumonia (VAP) emphasize early empiric broad-spectrum antibiotics. However, appropriate antibiotic de-escalation is also critical for optimal patient care.

Materials And Methods: We examined how often intensivists in our institution appropriately de-escalated antibiotics in cases of suspected VAP, and whether decision support by intensive care unit pharmacists could improve rates of antibiotic targeting and early antibiotic discontinuation in low-risk patients.

Main Results: A total of 92 (observation phase = 50; intervention phase = 42) patients with suspected VAP were identified. During the observation phase, 39 cases yielded positive sputum cultures, but in only 23 (59%) were antibiotics targeted to culture results. This rate improved during the intervention phase when 29 (91%) of 32 cases with positive cultures were targeted (P value .003). There were 48 cases in which the risk of pneumonia was considered low. Of the 26 low-risk cases in the observation phase, 5 (19%) had antibiotics discontinued early versus 5 (23%) of the 22 cases in the intervention phase.

Conclusions: Decision support by clinical pharmacists significantly improved rates of appropriate antibiotic targeting in cases of culture-positive suspected VAP but did not have a significant effect on early antibiotic discontinuation in patients at low risk of true pneumonia.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190014527316DOI Listing

Publication Analysis

Top Keywords

suspected vap
12
observation phase
12
antibiotic de-escalation
8
ventilator-associated pneumonia
8
appropriate antibiotic
8
decision support
8
antibiotic targeting
8
early antibiotic
8
antibiotic discontinuation
8
intervention phase
8

Similar Publications

Effects of Candida colonization on patients with ventilator-associated pneumonia and pathogenic microorganisms: Systematic review and meta-analysis.

Diagn Microbiol Infect Dis

January 2025

Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022 Hubei, PR China; Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022 Hubei, PR China. Electronic address:

Article Synopsis
  • The study reviews the impact of Candida colonization on mechanically ventilated ICU patients, finding that its prevalence ranges from 10% to 56% and is linked to worse patient outcomes.
  • It indicates that Candida colonization is associated with higher detection rates of harmful bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, particularly in patients who develop ventilator-associated pneumonia (VAP).
  • Despite the observed associations, Candida colonization did not significantly affect inflammatory markers, suggesting its role as a marker rather than a direct cause of inflammation.
View Article and Find Full Text PDF
Article Synopsis
  • There is a pressing need for new treatments for serious infections caused by Gram-negative bacteria, which the REVISIT study examined by evaluating aztreonam-avibactam against standard treatments in complicated infections.
  • The study involved a multinational, open-label design with adults who had complicated intra-abdominal infections or hospital-acquired pneumonia, comparing aztreonam-avibactam with meropenem or colistin over 5-14 days.
  • Results showed that out of 422 enrolled patients, 64% had identified Gram-negative pathogens, and the study aimed to determine clinical cure rates and safety without formal hypothesis testing.
View Article and Find Full Text PDF

Untargeted Blood Lipidomics Analysis in Critically Ill Pediatric Patients with Ventilator-Associated Pneumonia: A Pilot Study.

Metabolites

August 2024

Infectious Diseases Unit, 3rd Department Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece.

This study aims to explore the diagnostic potential of blood lipid profiles in suspected ventilator-associated pneumonia (VAP). Early detection of VAP remains challenging for clinicians due to subjective clinical criteria and the limited effectiveness of current diagnostic tests. Blood samples from 20 patients, with ages between 6 months and 15 years, were collected at days 1, 3, 6, and 12, and an untargeted lipidomics analysis was performed using a Ultra high Pressure Liquid Chromatography hyphenated with High Resolution Mass Spectrometry UPLC-HRMS (TIMS-TOF/MS) platform.

View Article and Find Full Text PDF

Background: Causative pathogens are currently identified in only a minority of pneumonia cases, which affects antimicrobial stewardship. Metagenomic next-generation sequencing (mNGS) has potential to enhance pathogen detection due to its sensitivity and broad applicability. However, while studies have shown improved sensitivity compared with conventional microbiological methods for pneumonia diagnosis, it remains unclear whether this can translate into clinical benefit.

View Article and Find Full Text PDF

Background: The utility of bronchoscopy in the treatment of patients with ventilator-associated pneumonia (VAP) has been proposed, although prior research has yielded inconclusive findings. This systematic review and meta-analysis were conducted to examine the impact of bronchoscopy on mortality rates, duration of mechanical ventilation (MV), and length of stay in the intensive care unit (ICU) among patients with VAP.

Methods: Relevant randomized controlled trials (RCTs) and cohort studies were acquired by conducting a comprehensive search in the PubMed, Embase, and Cochrane Library databases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!